title: [Apnea in newborns. When is the risk following maternal opioid treatment during labor over?].
authors: Barn- och ungdomskliniken, Norra Alvsborgs länssjukhus, Trollhättan. magnus.lichtenstein@vgregion.se
authors: Magnus
authors: M
authors: Lichtenstein
mesh_terms: D016362:Analgesia, Obstetrical / Q000009:adverse effects*; D000701:Analgesics, Opioid / Q000009:adverse effects*; D001049:Apnea / Q000139:chemically induced* / Q000188:drug therapy; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D015931:Intensive Care, Neonatal; D008297:Male; D008431:Maternal-Fetal Exchange / Q000187:drug effects*; D008614:Meperidine / Q000009:adverse effects*; D009270:Naloxone / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000627:therapeutic use; D011247:Pregnancy; D012307:Risk Factors; D013997:Time Factors
chemical_list: D000701:Analgesics, Opioid; D009292:Narcotic Antagonists; D009270:Naloxone; D008614:Meperidine